Celgene’s Multiple Sclerosis Pill: Everything You Have To Know About Its Success
Long before, Celgene has been considered as one of the leading American biotechnology company that discovers, develops and commercializes medicines for cancer and other inflammatory disorders. In its efforts to eradicate Multiple Sclerosis, Celgene has taken a huge leap forward towards becoming a major player in the multiple sclerosis treatment market. Just recently, the biotechnology company has made the announcement with regards to the positive results the company has obtained from a late-stage clinical trial of ozanimod.
Ozanimod: The Key For Multiple Sclerosis?
According to reports revealed by The Street, two doses of ozanimod has allegedly demonstrated a statistically significant superiority over Biogen's Avonex especially in terms of reducing the annual relapse rate for patients with relapsing multiple sclerosis. Additionally, researchers have revealed that the study has achieved the primary endpoint of the phase III study dubbed as Sunbeam trial. In the trial's course, ozanimod has also turned out to have bested Avonex by reducing the number of new brain lesions seen in multiple sclerosis patients, which has been a key secondary endpoint of the study.
Celgene's Success On Multiple Sclerosis
Meanwhile, as per Business Wire, Celgene's SUNBEAM trial has evaluated two orally administered treatment doses (0.5 mg and 1 mg) of ozanimod, with patients treated for at least one year. Consequently, the overall safety and tolerability profile was reportedly consistent with results from the previously reported phase II RMS (RADIANCE) and phase II ulcerative colitis (TOUCHSTONE) trials. In one of his statements, Bruce Cree, Associate Professor of Neurology, Multiple Sclerosis Center, Department of Neurology, University of California San Francisco said that these findings add to the growing body of evidence supporting the use of ozanimod as a disease modifying therapy for relapsing forms of multiple sclerosis.
On the other hand, experts said that multiple sclerosis has already become an increasingly crowded and competitive market for drug companies and might be particularly vulnerable to pricing pressures. As of the press time, Celgene was found to be on the move in developing ozanimod in other indications, such as ulcerative colitis and inflammatory bowel disease. Ultimately, it was found that Celgene could also acquire Biogen, however, company executives have highly emphasized that mega-mergers are not a priority at this time.
Does HIV Virus Attack Common Cells For A Quick Spread?
Considering the rapid progression of the HIV virus, do common cells make the progression even faster? What’s the truth behind claims that the HIV virus is attacking these common cells to spread the infection rapidly? Can we still do something to slow down and prevent this from worsening? Here’s what experts have to say
In Search Of ‘Planet 9’, NASA Wants Your Help; Details Inside
With NASA's continuous quest for space exploration, how far have they gone with their mission? What's the truth behind claims that NASA is now on the move to look for the so-called 'Planet 9' and that they have been asking for every person's help? How essential this help for them? Find out what authorities have to say
A Cure No More? Proposed Alzheimer’s Drug Is Virtually Not Effective, Researchers Say
Considering the continuous efforts in looking for the right solution to Alzheimer’s, why did Merck decided to stop initiating the last-stage trial of its own version of Alzheimer’s drug? What’s the truth behind claims that it’s not virtually effective? Is Alzheimer’s a hopeless case? Find out what experts have to say
The Controversial ‘Liberation Therapy’: Is It Good For Multiple Sclerosis?
With the number of advancements that has been intended for Multiple Sclerosis, why is the so-called ‘Liberation Therapy’ found to ineffective? What makes the said therapy to be considered as a failure when it comes to treating the auto-immune disease? Could it mean that it’s now a hopeless case for one of the world’s most dreaded diseases? Here’s what experts have to say
Multiple Sclerosis May Now Be Predicted Through Fatigue And Leg Dysfunction, Experts Say
Considering that the emergence of Multiple Sclerosis is still being considered as mysterious, are there ways to predict if a person is at risk of developing the said auto-immune disease? What’s the truth behind claims that Fatigue and Leg Dysfunction may be used as onset identifiers of the disease? Find out what health experts have to say
Recovery From Multiple Sclerosis Found In The So-Called 'tDCs' Technology, Details Inside
What is 'tDCs'? Considering that Multiple Sclerosis has been one of the world's fast emerging diseases, can the cure be found in this new technology called 'tDCs'? How can a patient recover from the aid auto-immune disease with the help of this technology? Here's what health professionals have to say
MORE IN ITECHPOST
Hackers Hear! Hackers See! Apple Is No Longer Safe!
Recent discoveries have found that Apple has been compromised and that hackers can access both your webcam and microphone.
[Japanese Simulation] The Next Mt. Fuji Volcano Eruption Could Leave Tokyo With 10 Times The Debris Compared to 2011 Tsunami
The Japanese government has decided to release a simulation to warn the people to prepare themselves adequately should Mt. Fuji Volcano erupt in the possibly near future.
Capcom's Resident Evil 3 Remake Hack: How to Defeat Nemesis
Capcom's Resident Evil 3 Remake brings back a powerful boss who is quite difficult to defeat. Here's how to defeat Nemesis!